Construction of 'OPS-5', New Plant to Manufacture Active Pharmaceutical Ingredients in Saga Factory Completed on September 1

Publication of Environmental and Social Report 2010
- Featuring approaches to help build a low-carbon, recycling-oriented society, development of environment-conscious products and social action programs -

21st Annual Outdoor Concert Held at Otsuka Pharmaceutical Tokushima Wajiki Factory Exciting Summer in Wajiki '10 on August 13, 2010

E Keppra® (levetiracetam) receives regulatory approval in Japan

SPRYCEL® (dasatinib) Receives FDA Priority Review for the Treatment of Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia (CML) in Chronic Phase

GW and Otsuka Agree Three Year Extension
to Global Cannabinoid Research Collaboration

Otsuka receives approval for Rapirun® H. Pylori Antibody Stick as in vitro diagnostic device on June 8, 2010

Otsuka Pharmaceutical Co., Ltd. Appoints the Board Members and Statutory Auditors (PDF:39KB)

Four-Year Follow-Up Data for SPRYCEL® (dasatinib)Demonstrate 82 Percent Overall Survival
in Patients with Chronic Myeloid Leukemia Who Failed Gleevec®

SPRYCEL® (dasatinib) Demonstrates Superior Confirmed Complete Cytogenetic
Response Rates Compared to Gleevec® in Study of Adult Patients with Newly Diagnosed
Chronic Myeloid Leukemia in Chronic Phase

Streptococcus pneumoniae Kit "RAPIRUN Pneumococcus" Approval obtained as in vitro diagnostic on May 26

First reader-participation collaboration
OTSUKA Health Comic Library Sequel Vol. 3
“We Are Children of the Earth: The Environment & Our Health”
March 31 publication for donation to elementary schools nationwide

Otsuka Pharmaceutical and Acucela Receive FDA Fast Track Designation for ACU-4429 in Patients with Dry AMD

FerriSeltz® powder 20%, MRI Oral GI Contrast Agent, Receives Additional Approval for GI Negative Imaging in Cholangiopancreatography

Rapid Assay Kit for RS virus, QUICKNAVI™-RSV, Launch on April 6

In-vitro Diagnostic Kit, WT1 mRNA Assay Kit "Otsuka" Application Filed for Additional Purpose of Use with Myelodysplastic Syndromes

New Medicated Skin Wash from UL･OS Line of Men's Face & Body Care Available from April 22, 2010

The Results of CSPS II, a Large-scale Clinical Trial of Cilostazol in Preventing Recurrent Strokes, Presented at American Stroke Association's International Stroke Conference on February 26

French Health Food Brand Gerblé to Debut in Japan Made from rigorously selected natural ingredients in southern France Test Marketing Begins April 6, 2010

InnerSignal UV Protect Make-up Base b Will Be Launched on March 1, 2010

Otsuka Pharmaceutical Co., Ltd. and Fuso Pharmaceutical Industries, Ltd. Conclude Agreement for the Manufacturing and Commercialization of Therapeutic Cancer Vaccine, OTS102